NCT01607879 2023-09-22
Use of β-hydroxy-β-methylbutyrate to Counteract Muscle Loss in Men With Prostate Cancer on Androgen Ablation
Medical College of Wisconsin
Phase 2 Completed
Clinical Trials
8 trialsNCT01983969 2020-01-27
Aza-SAHA-GBM With AutoSCT for Refractory Lymphoma
M.D. Anderson Cancer Center
Phase 1/2 Completed
NCT02589145 2019-12-13
Lenalidomide Combined With Vorinostat/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Diffuse Large B-Cell Lymphoma of the ABC Subtype
M.D. Anderson Cancer Center
Phase 1/2 Terminated
NCT01783522 2019-10-22
Glutamine in Preventing Peripheral Neuropathy in Patients With Multiple Myeloma Receiving Bortezomib
Case Comprehensive Cancer Center
Phase 2 Terminated
NCT02012608 2019-05-29
Glutamine for the Prevention of Radiation Toxicity in Subjects Conserving Therapy
University of Arkansas
Phase 2 Terminated
NCT00195013 2018-06-06
Randomized Placebo-Controlled Trial of Glutamine for Breast Cancer Patients With Peripheral Neuropathy
Weill Medical College of Cornell University
Phase 3 Completed
NCT00217724 2017-05-09
Glutamine in Preventing Myalgia and/or Arthralgia in Patients Who Are Receiving Paclitaxel For Cancer
OHSU Knight Cancer Institute
Phase NA Terminated
NCT00365768 2016-09-09
Glutamine in Treating Neuropathy Caused by Vincristine in Young Patients With Lymphoma, Leukemia, or Solid Tumors
Columbia University
Phase 2 Completed